Endothelial estrogen receptor isoforms and cardiovascular disease

Molecular and Cellular Endocrinology

Volumn 389, Issue 1-2, 2014, Pages 65-70

  Kim, Kyung Hee ^a   Young, Bryan D ^a   Bender, Jeffrey R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelium; ENOS; ER46; Estrogen

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ER46 PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MEMBRANE PROTEIN; NITRIC OXIDE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG; ESTROGEN; ISOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ESTROGEN RESPONSIVE ELEMENT; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; ANIMAL; METABOLISM;

ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; ESTROGENS; HUMANS; PROTEIN ISOFORMS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 84901502067     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.02.001     Document Type: Review

References (55)

1. Acconcia F., Ascenzi P., Bocedi A., Spisni E., Tomasi V., Trentalance A., Visca P., Marino M. Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17β-estradiol. Mol. Biol. Cell 2005, 16:231-237.
2. Adlanmerini M., Solinhac R., Abot A., Fabre A., Raymond-Letron I., Guihot A.L., Boudou F., Sautier L., Vessières E., Kim S.H., Lière P., Fontaine C., Krust A., Chambon P., Katzenellenbogen J.A., Gourdy P., Shaul P.W., Henrion D., Arnal J.F., Lenfant F. Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc. Natl. Acad. Sci. USA 2014, 111:E283-E290.
3. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., Black H., Bonds D., Brunner R., Brzyski R., Caan B., Chlebowski R., Curb D., Gass M., Hays J., Heiss G., Hendrix S., Howard B.V., Hsia J., Hubbell A., Jackson R., Johnson K.C., Judd H., Kotchen J.M., Kuller L., LaCroix A.Z., Lane D., Langer R.D., Lasser N., Lewis C.E., Manson J., Margolis K., Ockene J., O'Sullivan M.J., Phillips L., Prentice R.L., Ritenbaugh C., Robbins J., Rossouw J.E., Sarto G., Stefanick M.L., Van Horn L., Wactawski-Wende J., Wallace R., Wassertheil-Smoller S. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291:1701-1712. Women's Health Initiative Steering Committee.
4. Billon-Galés A., Fontaine C., Filipe C., Douin-Echinard V., Fouque M.J., Flouriot G., Gourdy P., Lenfant F., Laurell H., Krust A., Chambon P., Arnal J.F. The transactivating function 1 of estrogen receptor α is dispensable for the vasculoprotective actions of 17β-estradiol. Proc. Natl. Acad. Sci. USA 2009, 106:2053-2058.
5. Billon-Galés A., Krust A., Fontaine C., Abot A., Flouriot G., Toutain C., Berges H., Gadeau A.P., Lenfant F., Gourdy P., Chambon P., Arnal J.F. Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proc. Natl. Acad. Sci. USA 2011, 108:13311-13316.
6. Bondar G., Kuo J., Hamid N., Micevych P. Estradiol-induced estrogen receptor-α trafficking. J. Neurosci. 2009, 29:15323-15330.
7. Brand H., Kos M., Denger S., Flouriot G., Gromoll J., Gannon F., Reid G. A novel promoter is involved in the expression of estrogen receptor α in human testis and epididymis. Endocrinology 2002, 143:3397-3404.
8. Brouchet L., Krust A., Dupont S., Chambon P., Bayard F., Arnal J.F. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-α but not estrogen receptor-β. Circulation 2001, 103:423-428.
9. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engström O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389:753-758.
10. Chambliss K.L., Wu Q., Oltmann S., Konaniah E.S., Umetani M., Korach K.S., Thomas G.D., Mineo C., Yuhanna I.S., Kim S.H., Madak-Erdogan Z., Maggi A., Dineen S.P., Roland C.L., Hui D.Y., Brekken R.A., Katzenellenbogen J.A., Katzenellenbogen B.S., Shaul P.W. Non-nuclear estrogen receptor α signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J. Clin. Invest. 2010, 120:2319-2330.
11. Couse J.F., Curtis S.W., Washburn T.F., Lindzey J., Golding T.S., Lubahn D.B., Smithies O., Korach K.S. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 1995, 9:1441-1454.
12. Darblade B., Pendaries C., Krust A., Dupont S., Fouque M.J., Rami J., Chambon P., Bayard F., Arnal J.F. Estradiol alters nitric oxide production in the mouse aorta through the α-, but not β-, estrogen receptor. Circ. Res. 2002, 90:413-419.
13. Denger S., Reid G., Kos M., Flouriot G., Parsch D., Brand H., Korach K.S., Sonntag-Buck V., Gannon F. ERα gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol. Endocrinol. 2001, 15:2064-2077.
14. Dominguez R., Micevych P. Estradiol rapidly regulates membrane estrogen receptor alpha levels in hypothalamic neurons. J. Neurosci. 2010, 30:12589-12596.
15. Elhage R., Arnal J.F., Pieraggi M.T., Duverger N., Fiévet C., Faye J.C., Bayard F. 17β-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscl. Throm. Vasc. Biol. 1997, 17:2679-2684.
16. Figtree G.A., McDonald D., Watkins H., Channon K.M. Truncated estrogen receptor α 46-kDa isoform in human endothelial cells. Circulation 2003, 107:120-126.
17. Florian M., Lu Y., Angle M., Magder S. Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation. Steroids 2004, 69:637-645.
18. Flouriot G., Griffin C., Kenealy M., Sonntag-Buck V., Gannon F. Differentially expressed messenger RNA isoforms of the human estrogen receptor-α gene are generated by alternative splicing and promoter usage. Mol. Endocrinol. 1998, 12:1939-1954.
19. Flouriot G., Brand H., Denger S., Metivier R., Kos M., Reid G., Sonntag-Buck V., Gannon F. Identification of a new isoform of the human estrogen receptor-alpha (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J. 2000, 19:4688-4700.
20. Gilligan D.M., Quyyumi A.A., Cannon R.O. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994, 89:2545-2551.
21. Gorosito S.V., Lorenzo A.G., Cambiasso M.J. Estrogen receptor alpha is expressed on the cell-surface of embryonic hypothalamic neurons. Neuroscience 2008, 154:1173-1177.
22. Guo X., Razandi M., Pedram A., Kassab G., Levin E.R. Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors α and β. J. Biol. Chem. 2005, 280:19704-19710.
23. Haynes M.P., Li L., Sinha D., Russell K.S., Hisamoto K., Baron R., Collinge M., Sessa W.C., Bender J.R. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J. Biol. Chem. 2003, 278:2118-2123.
24. Hirata S., Shoda T., Kato J., Hoshi K. Isoform/variant mRNAs for sex steroid hormone receptors in humans. Trends Endocrinol. Metab. 2003, 14:124-129.
25. Iafrati M.D., Karas R.H., Aronovitz M., Kim S., Sullivan T.R., Lubahn D.B., O'Donnell T.F., Korach K.S., Mendelsohn M.E. Estrogen inhibits the vascular injury response in estrogen receptor-α-deficient mice. Nat. Med. 1997, 3:545-548.
26. Ishii H., Kobayashi M., Munetomo A., Miyamoto T., Sakuma Y. Novel splicing events and post-transcriptional regulation of human estrogen receptor αE isoforms. J. Steroid Biochem. Mol. Biol. 2013, 133:120-128.
27. Kim K.H., Bender J.R. Rapid, estrogen receptor-mediated signaling: why is the endothelium so special?. Sci. STKE 2005, 288:pe28.
28. Kim K.H., Toomre D., Bender J.R. Splice isoform estrogen receptors as integral transmembrane proteins. Mol. Biol. Cell 2011, 22:4415-4423.
29. Kiss A.L., Turi A., Müllner N., Kovács E., Botos E., Greger A. Oestrogen-mediated tyrosine phosphorylation of caveolin-1 and its effect on the oestrogen receptor localization: an in vivo study. Mol. Cell. Endocrinol. 2005, 245:128-137.
30. Kos M., Reid G., Denger S., Gannon F. Minireview: genomic organization of the human ERα gene promoter region. Mol. Endocrinol. 2001, 15:2057-2063.
31. Kos M., Denger S., Reid G., Gannon F. Upstream open reading frames regulate the translation of the multiple mRNA variants of the estrogen receptor α. J. Biol. Chem. 2002, 277:37131-37138.
32. Kousteni S., Bellido T., Plotkin L.I., O'Brien C.A., Bodenner D.L., Han L., Han K., DiGregorio G.B., Katzenellenbogen J.A., Katzenellenbogen B., Roberson P.K., Weinstein R.S., Jilka R.L., Manolagas S.C. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001, 104:719-730.
33. Kousteni S., Chen J.R., Bellido T., Han L., Ali A.A., O'Brien C.A., Plotkin L., Fu Q., Mancino A.T., Wen Y., Vertino A.M., Powers C.C., Stewart S.A., Ebert R., Parfitt A.M., Weinstein R.S., Jilka R.L., Manolagas S.C. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 2002, 298:843-846.
34. Li L., Haynes M.P., Bender J.R. Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc. Natl. Acad. Sci. USA 2003, 100:4807-4812.
35. Li L., Hisamoto K., Kim K.H., Haynes M.P., Bauer P.M., Sanjay A., Collinge M., Baron R., Sessa W.C., Bender J.R. Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation. Proc. Natl. Acad. Sci. USA 2007, 104:16468-16473.
36. Lin A.H., Li R.W., Ho E.Y., Leung G.P., Leung S.W., Vanhoutte P.M., Man R.Y. Differential ligand binding affinities of human estrogen receptor-α isoforms. PLoS One 2013, 8:e63199.
37. Longo M., Brama M., Marino M., Bernardini S., Korach K.S., Wetsel W.C., Scandurra R., Faraggiana T., Spera G., Baron R., Teti A., Migliaccio S. Interaction of estrogen receptor α with protein kinase C alpha and c-Src in osteoblasts during differentiation. Bone 2004, 34:100-111.
38. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994, 89:1501-1510.
39. Lubahn D.B., Moyer J.S., Golding T.S., Couse J.F., Korach K.S., Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA 1993, 90:11162-11166.
40. Mäkelä S., Savolainen H., Aavik E., Myllärniemi M., Strauss L., Taskinen E., Gustafsson J.A., Häyry P. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β. Proc. Natl. Acad. Sci. USA 1999, 96:7077-7082.
41. Márquez D.C., Pietras R.J. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 2001, 20:5420-5430.
42. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. New Engl. J. Med. 1999, 340:1801-1811.
43. Miesenböck G., De Angelis D.A., Rothman J.E. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 1998, 394:192-195.
44. Nakamura Y., Suzuki T., Miki Y., Tazawa C., Senzaki K., Moriya T., Saito H., Ishibashi T., Takahashi S., Yamada S., Sasano H. Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens. Mol. Cell. Endocrinol. 2004, 219:17-26.
45. Pare G., Krust A., Karas R.H., Dupont S., Aronovitz M., Chambon P., Mendelsohn M.E. Estrogen receptor-α mediates the protective effects of estrogen against vascular injury. Cir. Res. 2002, 90:1087-1092.
46. Razandi M., Alton G., Pedram A., Ghonshani S., Webb P., Levin E.R. Identification of a structural determinant necessary for the localization and function of estrogen receptor α at the plasma membrane. Mol. Cell. Biol. 2003, 23:1633-1646.
47. Riggs B.L., Hartmann L.C. Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. New Engl. J. Med. 2003, 348:618-629.
48. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. Writing Group for the Women's Health Initiative Investigators.
49. Russell K.S., Haynes M.P., Sinha D., Clerisme E., Bender J.R. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc. Natl. Acad. Sci. USA 2000, 97:5930-5935.
50. Schierbeck L.L., Rejnmark L., Tofteng C.L., Stilgren L., Eiken P., Mosekilde L., Køber L., Jensen J.E. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012, 345:e6409.
51. Shi L., Dong B., Li Z., Lu Y., Ouyang T., Li J., Wang T., Fan Z., Fan T., Lin B., Wang Z., Xie Y. Expression of ER-α36, a novel variant of estrogen receptor α, and resistance to tamoxifen treatment in breast cancer. J. Clin. Oncol. 2009, 27:3423-3429.
52. Thompson D.A., McPherson L.A., Carmeci C., deConinck E.C., Weigel R.J. Identification of two estrogen receptor transcripts with novel 5' exons isolated from a MCF7 cDNA library. J. Steroid Biochem. Mol. Biol. 1997, 62:143-153.
53. Truss M., Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr. Rev. 1993, 14:459-479.
54. Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F. A variant of estrogen receptor-α, hER-α36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Natl. Acad. Sci. USA 2006, 103:9063-9068.
55. Zivadinovic D., Watson C.S. Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res. 2005, 7:R130-R144.